{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:53:52Z","timestamp":1775267632447,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,5,24]],"date-time":"2013-05-24T00:00:00Z","timestamp":1369353600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00428-013-1425-1","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T21:42:27Z","timestamp":1369258947000},"page":"603-607","source":"Crossref","is-referenced-by-count":6,"title":["HER2 protein expression and HER2 gene amplification are infrequent in small intestinal carcinomas"],"prefix":"10.1007","volume":"462","author":[{"name":"The Korean Small Intestinal Cancer Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Jin","family":"Gu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Mo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,24]]},"reference":[{"key":"1425_CR1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.5858\/arpa.2011-0168-RS","volume":"136","author":"JF Hechtman","year":"2012","unstructured":"Hechtman JF, Polydorides AD (2012) HER2\/neu gene amplification and protein overexpression in gastric and gastroesophageal junction adenocarcinoma: a review of histopathology, diagnostic testing, and clinical implications. Arch Pathol Lab Med 136:691\u2013697","journal-title":"Arch Pathol Lab Med"},{"key":"1425_CR2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 235:177\u2013182","journal-title":"Science"},{"key":"1425_CR3","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/ijc.26292","volume":"130","author":"TC Chua","year":"2012","unstructured":"Chua TC, Merrett ND (2012) Clinicopathologic factors associated with HER2-positive gastric cancer and its impact on survival outcomes\u2014a systematic review. Int J Cancer 130:2845\u20132856","journal-title":"Int J Cancer"},{"key":"1425_CR4","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.3748\/wjg.v18.i19.2402","volume":"18","author":"HZ Dang","year":"2012","unstructured":"Dang HZ, Yu Y, Jiao SC (2012) Prognosis of HER2 over-expressing gastric cancer patients with liver metastasis. World J Gastroenterol 18:2402\u20132407","journal-title":"World J Gastroenterol"},{"key":"1425_CR5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2407-12-74","volume":"12","author":"R Schillaci","year":"2012","unstructured":"Schillaci R, Guzman P, Cayrol F, Beguelin W, Diaz Flaque MC, Proietti CJ, Pineda V, Palazzi J, Frahm I, Charreau EH, Maronna E, Roa JC, Elizalde PV (2012) Clinical relevance of ErbB-2\/HER2 nuclear expression in breast cancer. BMC Cancer 12:74. doi: 10.1186\/1471-2407-12-74","journal-title":"BMC Cancer"},{"key":"1425_CR6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1309\/AJCPK6QHNNOEMJIM","volume":"134","author":"OT Chan","year":"2010","unstructured":"Chan OT, Chen ZM, Chung F, Kawachi K, Phan DC, Himmelfarb E, Lin F, Perry A, Wang HL (2010) Lack of HER2 overexpression and amplification in small intestinal adenocarcinoma. Am J Clin Pathol 134:880\u2013885","journal-title":"Am J Clin Pathol"},{"key":"1425_CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7150\/jca.4090","volume":"3","author":"JT Jorgensen","year":"2012","unstructured":"Jorgensen JT, Hersom M (2012) HER2 as a prognostic marker in gastric cancer\u2014a systematic analysis of data from the literature. J Cancer 3:137\u2013144","journal-title":"J Cancer"},{"key":"1425_CR8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ijc.10257","volume":"98","author":"T Takehana","year":"2002","unstructured":"Takehana T, Kunitomo K, Kono K, Kitahara F, Iizuka H, Matsumoto Y, Fujino MA, Ooi A (2002) Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. Int J Cancer 98:833\u2013837","journal-title":"Int J Cancer"},{"key":"1425_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2407-6-123","volume":"6","author":"B Schuell","year":"2006","unstructured":"Schuell B, Gruenberger T, Scheithauer W, Zielinski C, Wrba F (2006) HER 2\/neu protein expression in colorectal cancer. BMC Cancer 6:123. doi: 10.1186\/1471-2407-6-123","journal-title":"BMC Cancer"},{"key":"1425_CR10","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/sj.bjc.6605449","volume":"102","author":"MJ Overman","year":"2010","unstructured":"Overman MJ, Pozadzides J, Kopetz S, Wen S, Abbruzzese JL, Wolff RA, Wang H (2010) Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine. Br J Cancer 102:144\u2013150","journal-title":"Br J Cancer"},{"key":"1425_CR11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9098(199602)61:2<100::AID-JSO3>3.0.CO;2-G","volume":"61","author":"L Zhu","year":"1996","unstructured":"Zhu L, Kim K, Domenico DR, Appert HE, Howard JM (1996) Adenocarcinoma of duodenum and ampulla of Vater: clinicopathology study and expression of p53, c-neu, TGF-alpha, CEA, and EMA. J Surg Oncol 61:100\u2013105","journal-title":"J Surg Oncol"},{"key":"1425_CR12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","volume":"25","author":"CA Hudis","year":"2007","unstructured":"Hudis CA, Barlow WE, Costantino JP, Gray RJ, Pritchard KI, Chapman JA, Sparano JA, Hunsberger S, Enos RA, Gelber RD, Zujewski JA (2007) Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol 25:2127\u20132132","journal-title":"J Clin Oncol"},{"key":"1425_CR13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK, ToGA Trial Investigators (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376:687\u2013697","journal-title":"Lancet"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1425-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-013-1425-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-013-1425-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:36:09Z","timestamp":1559064969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-013-1425-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,24]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1007\/s00428-013-1425-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,24]]}}}